To view this email as a web page, click here.
 
November 30, 2017
Cutaneous side effects of melanoma drugs
Dermatologists need "hands on" experience, researchers report at EADV 2017 in Geneva.
Read more
 
ADVERTISEMENT
 
Recapture remission in chronic idiopathic urticaria
In CIU, omalizumab retreatment recaptures remission in relapsers following drug withdrawal.
Read more
 
Secukinumab safe and effective through 5 years in psoriasis
Patients were continually treated with the 300 mg for five years, researchers report at EADV 2017 in Geneva.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.